Overview
This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.
Eligibility
Inclusion Criteria:
- Presence of a renal mass up to 4 cm
- Adult \> 18 years
- Candidate to renal surgery
- Informed consent signed
Exclusion Criteria:
- Contraindication for MRI


